Return to Article Details
NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IkB-a/NF-kB signaling pathway activity
Download
Download PDF
https://cellmolbiol.org/index.php/CMB
Themes by Openjournaltheme.com
Themes by Openjournaltheme.com